Cite
HARVARD Citation
Nikkho, S. et al. (2022). Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension. Pulmonary circulation. p. n/a. [Online].